The FDA has issued its “Strategic Plan for Risk Communication,” which outlines how the agency intends to communicate information about the risks and benefits of FDA-regulated products with various public audiences, including health professionals, patients, and consumers. The plan includes more than 70 actions the FDA plans to take over the next five years to: strengthen the science that supports effective risk communication; expand FDA’s capacity to generate, disseminate, and oversee effective risk communication; and optimize FDA policies on communicating risks and benefits.